JP2006131633A5 - - Google Patents

Download PDF

Info

Publication number
JP2006131633A5
JP2006131633A5 JP2005320134A JP2005320134A JP2006131633A5 JP 2006131633 A5 JP2006131633 A5 JP 2006131633A5 JP 2005320134 A JP2005320134 A JP 2005320134A JP 2005320134 A JP2005320134 A JP 2005320134A JP 2006131633 A5 JP2006131633 A5 JP 2006131633A5
Authority
JP
Japan
Prior art keywords
agent
compound
formula
inhibits
aging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005320134A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006131633A (ja
Filing date
Publication date
Priority claimed from FR0411783A external-priority patent/FR2877220B1/fr
Application filed filed Critical
Publication of JP2006131633A publication Critical patent/JP2006131633A/ja
Publication of JP2006131633A5 publication Critical patent/JP2006131633A5/ja
Pending legal-status Critical Current

Links

JP2005320134A 2004-11-04 2005-11-02 皮膚の老化の徴候を抑制する尿素化合物の使用 Pending JP2006131633A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0411783A FR2877220B1 (fr) 2004-11-04 2004-11-04 Utilisation de composes d'uree pour lutter contre les signes du vieillissement cutane

Publications (2)

Publication Number Publication Date
JP2006131633A JP2006131633A (ja) 2006-05-25
JP2006131633A5 true JP2006131633A5 (https=) 2008-12-18

Family

ID=34950464

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005320134A Pending JP2006131633A (ja) 2004-11-04 2005-11-02 皮膚の老化の徴候を抑制する尿素化合物の使用

Country Status (5)

Country Link
EP (1) EP1674072B1 (https=)
JP (1) JP2006131633A (https=)
CA (1) CA2524653A1 (https=)
ES (1) ES2492915T3 (https=)
FR (1) FR2877220B1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2902999B1 (fr) 2006-07-03 2012-09-28 Oreal Utilisation de derives c-glycoside a titre d'actif prodesquamant
EP2063860A1 (en) * 2006-09-20 2009-06-03 Chanel Parfums Beauté Cosmetic use of active agents that stimulate matriptase expression
FR2918269B1 (fr) 2007-07-06 2016-11-25 Oreal Composition de protection solaire contenant l'association d'un polymere semi-cristallin et de particules de latex creuses.
FR2918561B1 (fr) 2007-07-09 2009-10-09 Oreal Utilisation pour la coloration de la peau de l'acide dehydroascorbique ou des derives polymeres ; procedes de soin et/ou de maquillage.
FR2918563B1 (fr) 2007-07-12 2009-12-04 Oreal Composition photoprotectrice fluide aqueuse a base d'un polymere polyamide a terminaison amide tertiaire.
FR2924613B1 (fr) * 2007-12-10 2012-12-21 Oreal Utilisation cosmetique de proteines de type hsp27.
FR2925314B1 (fr) * 2007-12-19 2012-11-23 Oreal Utilisation cosmetique de proteines de type transglutaminase 3
FR2931064B1 (fr) 2008-05-14 2010-08-13 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un derive de pyrrolidinone; procede de photostabilisation du derive de dibenzoylmethane
FR2936706B1 (fr) 2008-10-08 2010-12-17 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane
FR2939036B1 (fr) 2008-12-01 2010-12-17 Oreal Procede de coloration artificielle de la peau utilisant un melange de carotenoide et de colorant vert lidophile ; nouveau melange de colorants lipophiles ; composition
FR2940608B1 (fr) 2008-12-30 2011-04-22 Oreal Utilisation de monosaccharides et composition
FR2940612B1 (fr) 2008-12-30 2011-05-06 Oreal Association de monosaccharides avec l'acide ascorbique et son utilisation en cosmetique
FR2940611B1 (fr) 2008-12-30 2012-01-13 Oreal Association de monosaccharides et d'adenosine et son utilisation en cosmetique
FR2940610B1 (fr) 2008-12-30 2011-05-06 Oreal Association de monosaccharides avec des derives c-glycosides et son utilisation en cosmetique
FR2940613B1 (fr) 2008-12-30 2012-09-21 Oreal Association de monosaccharides avec des filtres solaires et son utilisation en cosmetique
FR2940615B1 (fr) 2008-12-30 2011-12-30 Oreal Association de monosaccharides avec des agents antioxydants et son utilisation en cosmetique
FR2940609B1 (fr) 2008-12-30 2011-05-06 Oreal Association de monosaccharides et d'agents desquamants et son utilisation en cosmetique
CN103260596B (zh) 2009-12-18 2016-08-31 莱雅公司 包括能原位缩合的化合物和遮挡uv辐射的试剂的化妆处理方法
FR2960773B1 (fr) 2010-06-03 2015-12-11 Oreal Procedes de traitement cosmetique utilisant un revetement a base d'un polymere polyamide-polyether
FR2979540B1 (fr) 2011-09-06 2013-12-27 Oreal Association de carraghenane et de c-glycoside et leurs utilisations
MX378180B (es) * 2014-06-17 2025-03-10 Procter & Gamble Composicion para la reduccion del encrespado del cabello
US10632054B2 (en) 2015-04-02 2020-04-28 The Procter And Gamble Company Method for hair frizz reduction
US10406094B2 (en) 2016-04-01 2019-09-10 The Procter And Gamble Company Composition for fast dry of hair
WO2025176869A1 (fr) * 2024-02-21 2025-08-28 Mayan Pharma Nouveaux dérivés urées de macrolides amphotères et solubilisation d'antibiotiques amphotères par des dérivés urées de glucides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2703185A1 (de) * 1977-01-27 1978-08-10 Henkel Kgaa Kosmetische mittel mit einem gehalt an haut-feuchthaltemitteln
EP0585130B1 (en) * 1992-08-27 1998-01-28 Shiseido Company Limited External preparation for skin containing a depigmentation agent
EP1005333B1 (en) * 1997-02-25 2005-01-12 The Regents Of The University Of Michigan Methods and compositions for preventing and treating chronological aging in human skin
JP2004075661A (ja) * 2002-06-18 2004-03-11 Shiseido Co Ltd 表皮基底膜ケアを特徴とする皮膚外用剤、皮膚基底膜構造形成促進剤および人工皮膚の製造方法
FR2848116B1 (fr) * 2002-12-10 2007-01-05 Nuxe Lab Composition cosmetique comprenant un inhibiteur des metallo-proteinases et un lipopeptide.

Similar Documents

Publication Publication Date Title
JP2006131633A5 (https=)
BRPI0514420A (pt) peptìdeo, variante do mesmo, ou um sal farmaceuticamente aceitável do mesmo, composição, uso de um peptìdeo ou de uma variante de peptìdeo, substrato, e, métodos de tratamento ou prevenção de um infecção microbiana, e de tratamento de uma ferida em um indivìduo
CN101687022A8 (zh) Prame衍生的肽以及包括该肽的免疫原组合物
ES2330291A1 (es) Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
BR0009043A (pt) Composto, composição farmacêutica, e, método de tratar uma doença em um animal em que a atividade da cisteìna protease contribui para a patologia e/ou sintomatologia da doença
ATE446313T1 (de) Muteine von tränen-lipocalin
EP1614675A3 (en) Amino acids with affinity for the alpha-2-delta protein
DE602006015592D1 (de) Orodispersible pharmazeutische Zusammensetzung für die orale, oromukosale oder sublinguale Verabreichung von Agomelatin
ATE333451T1 (de) Verwendung von nitrilenverbindungen als arztneimittel
ATE437679T1 (de) Wässrige antitranspirant formulierung
ITMI20031396A1 (it) Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante.
DE60307665D1 (de) Haarbehandlungszusammensetzungen mit xanthin und alpha-hydroxysäure
ATE527377T1 (de) Erstellung von genexpressionprofilen aus ffpe- proben
WO2007021886A3 (en) Truncated memapsin 2 for use for treating alzheimer's disease
BRPI0408299A (pt) inibidores de catepsina s
ES2593040T3 (es) Utilización de compuestos de urea para favorecer la descamación
ATE521329T1 (de) Säuregepufferte körperpflege zusammensetzungen
BRPI0412453A (pt) uso do ácido ascórbico ou um sal fisiologicamente aceitável do mesmo
NO20023248D0 (no) Nukleinsyrer som koder for (poly)peptider med CHIPS-aktivitet
EP2308837A3 (en) Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors
HRP20080178T3 (hr) Farmaceutski pripravak u obliku hidrogela za transdermalnu primjenu aktivnih tvari
CY1111004T1 (el) Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης